Stalevo 175 mg/43.75 mg/200 mg film-coated tablets

Package leaflet: Information for the user

Introduction

Package leaflet: information for the user

Stalevo 175 mg/43.75 mg/200 mg film-coated tablets

levodopa/carbidopa/entacapone

Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it may harm them.
• If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.

Leaflet contents

1. What Stalevo is and what it is used for
2. What you need to know before taking Stalevo
3. How to take Stalevo
4. Possible side effects
5. How to store Stalevo
6. Contents of the pack and other information

1. What Stalevo is and what it is used for

Stalevo contains three active substances (levodopa, carbidopa, and entacapone) in a film-coated tablet. Stalevo is used to treat Parkinson's disease.

Parkinson's disease is due to a low concentration in the brain of a substance called dopamine. Levodopa increases the amount of dopamine and thereby reduces the symptoms of Parkinson's disease. Carbidopa and entacapone enhance the anti-Parkinsonian effects of levodopa.

2. What you need to know before taking Stalevo

Do not take Stalevo if

• you are allergic to levodopa, carbidopa, or entacapone, or to any of the other ingredients of this medicine (listed in section 6)
• you have narrow-angle glaucoma (an eye disorder)
• you have a tumor of the adrenal glands
• you are taking certain medicines for depression (combinations of selective MAO-A and MAO-B inhibitors, or non-selective MAO inhibitors)
• you have ever had neuroleptic malignant syndrome (NMS – a rare reaction to medicines used to treat serious mental disorders)
• you have ever had non-traumatic rhabdomyolysis (a rare muscle disorder)
• you have severe liver disease.

Warnings and precautions

Talk to your doctor or pharmacist before taking Stalevo if you have or have ever had:

• a heart attack or any other heart or blood vessel disorder, including arrhythmias
• asthma or any other lung disease
• any liver problems, as your dose may need to be adjusted
• any kidney disease or hormone-related disorders
• stomach ulcer or seizures
• prolonged diarrhea. Consult your doctor, as this may be a sign of inflammation of the colon
• any type of serious mental disorder, such as psychosis
• open-angle glaucoma, as your dose may need to be adjusted and your intraocular pressure monitored.

Talk to your doctor if you are taking:

• antipsychotics (medicines used to treat psychosis)
• any medicine that may cause a drop in blood pressure when standing up from a chair or bed. You should know that Stalevo may worsen these reactions.

Talk to your doctor if, while taking Stalevo, you:

• experience severe muscle stiffness, violent muscle contractions, tremors, agitation, confusion, fever, rapid pulse, or large fluctuations in blood pressure. If any of these occur, contact your doctor immediately.
• feel depressed, have suicidal thoughts, or notice unusual changes in your behaviour.
• start falling asleep suddenly or feel very sleepy. If this happens, you must not drive or operate tools or machinery (see also section “Driving and use of machines”).
• begin to experience uncontrolled movements or they worsen. If this occurs, your doctor may need to adjust your dose.
• experience diarrhea: monitoring your weight is recommended to prevent excessive weight loss.
• experience progressive loss of appetite, asthenia (weakness, exhaustion), and weight loss over a relatively short period. In such cases, a full medical evaluation including liver function tests should be considered.
• are considering stopping Stalevo, refer to the section “If you stop taking Stalevo”.

Inform your doctor if you, or your family/caregiver, notice that you are developing symptoms similar to addiction, leading to a desire for high doses of Stalevo and other medicines used to treat Parkinson’s disease.

Inform your doctor if you or your family/caregiver notice that you are developing urges or a tendency to behave in ways that are unusual for you, or that you cannot resist the impulse, drive, or temptation to carry out certain activities that may harm you or others. These behaviours are known as impulse control disorders and may include gambling addiction, compulsive eating, excessive spending, or abnormally increased sex drive or preoccupation with increased sexual thoughts or feelings. Your doctor may need to review your treatment.

During long-term treatment with Stalevo, your doctor may carry out blood tests regularly.

If you are due to have surgery, you must tell your doctor that you are taking Stalevo.

Stalevo is not recommended for the treatment of extrapyramidal symptoms (e.g. involuntary movements, restlessness, muscle rigidity, and muscle contractions) caused by other medicines.

Children and adolescents

Experience with the use of Stalevo in patients under 18 years of age is limited. Therefore, Stalevo is not recommended for use in children or adolescents.

Other medicines and Stalevo

Tell your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.

Do not take Stalevo if you are taking certain medicines for depression (combinations of selective MAO-A and MAO-B inhibitors, or non-selective MAO inhibitors).

Stalevo may increase the effect and also the adverse effects of certain medicines. These include:

• medicines used to treat depression, such as moclobemide, amitriptyline, desipramine, maprotiline, venlafaxine, and paroxetine
• rimiterol and isoprenaline, used to treat respiratory diseases
• adrenaline, used for severe allergic reactions
• noradrenaline, dopamine, and dobutamine, used to treat heart conditions and low blood pressure
• alpha-methyldopa, used to treat high blood pressure
• apomorphine, used to treat Parkinson’s disease.

Certain medicines may reduce the effects of Stalevo. These medicines are:

• dopamine antagonists used to treat mental disorders, nausea, and vomiting
• phenytoin, used to prevent seizures
• papaverine, used to relax muscles.

Stalevo may interfere with iron absorption in the gut. Therefore, you should not take Stalevo at the same time as iron supplements. If you take either, wait at least 2 to 3 hours before taking the other.

Taking Stalevo with food and drink

Stalevo may be taken with or without food. In some patients, Stalevo may not be well absorbed if taken with high-protein foods (meat, fish, dairy products, cereals, and nuts) or shortly after eating them. Consult your doctor if you think this applies to you.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.

You must not breastfeed while being treated with Stalevo.

Driving and use of machines

Stalevo may lower your blood pressure, which may cause dizziness or fainting. Therefore, take special care when operating tools or machinery.

If you feel very tired or notice that you fall asleep suddenly, wait until you feel fully awake again before driving or doing anything else that requires alertness. Otherwise, you may put yourself and others at risk of a serious or even fatal accident.

Stalevo contains sucrose

Stalevo contains sucrose (1.89 mg/tablet). If your doctor has told you that you have an intolerance to certain sugars, consult him before taking this medicine.

This medicine contains less than 1 mmol of sodium (23 mg) per maximum recommended daily dose, i.e., essentially "sodium-free".

3. How to take Stalevo

Follow exactly the instructions for using this medicine as given by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

Adults and elderly:

• Your doctor will tell you the exact number of Stalevo tablets to take each day.
• The tablets must not be split or divided into smaller pieces.
• Take only one tablet at a time.
• Depending on your response to treatment, your doctor may instruct you to increase or decrease the dose.
• If you are taking Stalevo 175 mg/43.75 mg/200 mg tablets, do not take more than 8 tablets per day.

Talk to your doctor or pharmacist if you think that the effect of Stalevo is too strong or too weak, or if you experience possible adverse effects.

If you take more Stalevo than you should

If you have accidentally taken more Stalevo tablets than prescribed, speak to your doctor or pharmacist immediately. In case of overdose, you may feel confused or agitated, your heartbeat may become slower or faster than normal, or you may notice a change in the colour of your skin, tongue, eyes, or urine.

If you forget to take Stalevo

Do not take a double dose to make up for missed doses.

If more than 1 hour remains until the next dose:

Take one tablet as soon as you remember, and take the next one at the usual time.

If less than 1 hour remains until the next dose:

Take one tablet as soon as you remember, wait 1 hour, and then take another tablet. After that, continue as usual.

There must always be at least one hour between doses of Stalevo to avoid possible adverse effects.

If you stop taking Stalevo

Do not stop taking Stalevo unless your doctor tells you to. In such a case, your doctor may need to adjust the dose of your other Parkinson's medications, especially levodopa, to ensure adequate symptom control. If you suddenly stop taking Stalevo and other Parkinson's medications, you may experience unwanted adverse effects.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them. Many of them can be relieved by adjusting the dose.

If you experience any of the following symptoms during treatment with Stalevo, contact your doctor immediately:

• Severe muscle stiffness or violent muscle contractions, tremors, agitation, confusion, fever, rapid pulse, or large fluctuations in blood pressure. These may be symptoms of neuroleptic malignant syndrome (NMS, a rare but serious reaction to medicines used to treat disorders of the central nervous system) or rhabdomyolysis (a rare and serious muscle disorder).
• Allergic reaction characterized by signs such as hives, itching, rash, and swelling of the face, lips, tongue, or throat. This reaction may cause difficulty breathing or swallowing.

Very common (may affect more than 1 in 10 people):

• Uncontrolled movements (dyskinesias)
• Feeling unwell (nausea)
• Harmless reddish-brown discoloration of the urine
• Muscle pain
• Diarrhea.

Common (may affect up to 1 in 10 people):

• Fainting or collapse due to low blood pressure, hypertension
• Worsening of parkinsonism symptoms, dizziness, drowsiness
• Vomiting, abdominal pain and discomfort, heartburn, dry mouth, constipation
• Inability to sleep, hallucinations, confusion, abnormal dreams (with nightmares), tiredness
• Changes in mental state, including memory problems, anxiety and depression (possibly with suicidal thoughts)
• Heart or vascular problems (e.g., chest pain), irregular heartbeat
• More frequent falls
• Shortness of breath
• Increased sweating, rashes
• Muscle cramps, swelling of the legs
• Blurred vision
• Anaemia
• Decreased appetite, weight loss
• Headache, joint pain
• Urinary tract infections.

Uncommon (may affect up to 1 in 100 people):

• Heart attack
• Intestinal bleeding
• Changes in blood cell counts that may lead to bleeding, abnormalities in liver function tests
• Seizures
• Restlessness
• Psychotic symptoms
• Colitis (inflammation of the colon)
• Skin, nail, hair, or sweat discoloration other than that of the urine
• Difficulty swallowing
• Inability to urinate.

Frequency not known (cannot be estimated from available data):

Desire to take high doses of Stalevo exceeding those required to control motor symptoms, known as dopamine dysregulation syndrome. Some patients may experience severe abnormal involuntary movements (dyskinesias), mood changes, or other adverse effects after taking high doses of Stalevo.

The following adverse effects have also been reported:

• Hepatitis (inflammation of the liver)
• Itching.

You may experience the following adverse effects:

• Inability to resist the impulse to carry out an action that could be harmful, which may include:
• A strong urge to gamble excessively despite serious personal or family consequences
• Increased or altered interest in sex and behaviour that is concerning to you or others, such as increased sexual urges
• Excessive or uncontrolled shopping or spending
• Excessive (eating large amounts of food in short periods of time) or compulsive eating (eating more food than usual and more than necessary to satisfy hunger).

Inform your doctor if you experience any of these behaviours; they will discuss how to manage or reduce these symptoms.

Reporting of adverse effects

If you experience any adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Stalevo

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the carton. The expiry date is the last day of the month indicated.

No special storage conditions are required.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines and packaging that you no longer need. This will help protect the environment.

6. Contents of the pack and other information

Composition of Stalevo

• The active substances in Stalevo are levodopa, carbidopa and entacapone.
• Each Stalevo 175 mg/43.75 mg/200 mg tablet contains 175 mg of levodopa, 43.75 mg of carbidopa and 200 mg of entacapone.
• The other components of the tablet core are croscarmellose sodium, magnesium stearate, maize starch, mannitol (E421) and povidone (E1201).
• The components of the film coating are glycerol 85 percent (E422), hypromellose, magnesium stearate, polysorbate 80, iron oxide red (E172), sucrose and titanium dioxide (E171).

Appearance of the product and contents of the container

Stalevo 175 mg/43.75 mg/200 mg: oval, unmarked, film-coated tablets, light reddish-brown in colour, with "LCE 175" printed on one side.

There are five different pack sizes of Stalevo 175 mg/43.75 mg/200 mg (containing 10, 30, 100, 130 or 175 tablets). Only certain pack sizes may be marketed.

Marketing Authorization Holder

Orion Corporation

Orionintie 1

FI-02200 Espoo

Finland

Manufacturer

Orion Corporation Orion Pharma

Joensuunkatu 7

FI-24100 Salo

Finland

For more information about this medicinal product, please contact the local representative of the Marketing Authorization Holder.

Date of the most recent review of this leaflet:

Other sources of information

Detailed information on this medicinal product is available on the European Medicines Agency website: https://www.ema.euopa.eu.